- Tytuł:
- Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA)
- Autorzy:
- Źródło:
- In Journal of Clinical Virology August 2018 105:112-117
Czasopismo naukowe